abrdn Life Sciences Investors Shares of Beneficial Interest (HQL)
Other Income/Expenses (Net)
$0.00
Quarterly · Period ending: · USD
HQL Other Income/Expenses (Net)
Latest reported$0.00period ending
Latest reported$0.00period ending
HQL Quarterly Other Income/Expenses (Net) ($11.64M → $0.00)
Quarterly Other Income/Expenses (Net)
High-resolution chart · PNG
HQL other income/expenses (net) history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Other Income/Expenses (Net) (USD) |
|---|---|
| 0 | |
| 0 | |
| -45,858,991 | |
| 36,307,027 | |
| 50,909,782 | |
| -2,985 | |
| 34,743,701 | |
| -27,004,573 | |
| 2,417 | |
| 12,059 | |
| -7,830 | |
| -12,513 | |
| 1,336 | |
| -30,058,034 | |
| -37,541,546 | |
| 50,235,044 | |
| -17,963,704 | |
| 43,863,878 | |
| 28,570,572 | |
| 59,138,000 | |
| -69,289,983 | |
| -50,553,193 | |
| 93,437,854 | |
| 55,771,010 | |
| 37,262,026 | |
| 60,320,300 | |
| 13,747 | |
| 23,564,172 | |
| 55,349,343 | |
| 20,635,000 | |
| 20,635,000 | |
| 6,075,000 | |
| 6,075,000 | |
| -9,260,000 | |
| -9,260,000 | |
| 31,585,000 | |
| 31,585,000 | |
| 26,110,000 | |
| 26,110,000 | |
| -10,050,000 | |
| -10,050,000 | |
| 23,675,000 | |
| 23,675,000 | |
| 5,115,000 | |
| 5,115,000 | |
| 20,480,000 | |
| 20,480,000 | |
| -23,945,000 | |
| -23,945,000 | |
| -46,545,000 | |
| -46,545,000 | |
| -14,315,000 | |
| -14,315,000 | |
| 8,360,000 | |
| 8,360,000 | |
| 11,640,000 | |
| 11,640,000 |